CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 92 filers reported holding CONCERT PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $318,000 | -28.1% | 23,300 | 0.0% | 0.13% | +6.5% |
| Q4 2015 | $442,000 | +1.1% | 23,300 | 0.0% | 0.12% | +47.6% |
| Q3 2015 | $437,000 | -89.3% | 23,300 | -91.5% | 0.08% | -78.3% |
| Q2 2015 | $4,102,000 | -5.3% | 275,500 | -3.7% | 0.39% | -5.4% |
| Q1 2015 | $4,333,000 | +10.7% | 286,100 | -2.6% | 0.41% | +9.1% |
| Q4 2014 | $3,913,000 | +5.6% | 293,800 | 0.0% | 0.38% | -1.8% |
| Q3 2014 | $3,705,000 | +13.4% | 293,800 | -9.2% | 0.38% | +35.9% |
| Q2 2014 | $3,268,000 | -24.4% | 323,600 | +0.7% | 0.28% | -20.4% |
| Q1 2014 | $4,320,000 | – | 321,200 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,253,000 | $7,097,000 | 0.26% |
| INGALLS & SNYDER LLC | 1,358,573 | $4,280,000 | 0.19% |
| RA Capital Management | 3,033,603 | $9,556,000 | 0.17% |
| Kensington Investment Counsel, LLC | 85,483 | $269,000 | 0.16% |
| Perceptive Advisors | 4,301,282 | $13,548,000 | 0.10% |
| NewEdge Wealth, LLC | 381,326 | $1,201,000 | 0.05% |
| Black Diamond Financial, LLC | 46,000 | $145,000 | 0.05% |
| Birchview Capital, LP | 20,000 | $63,000 | 0.04% |
| XTX Topco Ltd | 14,305 | $45,000 | 0.02% |
| Alyeska Investment Group, L.P. | 548,090 | $1,726,000 | 0.02% |